These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 17639667)
1. [Preventing cardiovascular disease in type 2 diabetes. From evidence based medicine to patient based reality]. Arnold-Kunz G; Ruiz J Rev Med Suisse; 2007 Jun; 3(114):1456-8, 1460-2. PubMed ID: 17639667 [TBL] [Abstract][Full Text] [Related]
2. [Preventing type 2 diabetes complications: from evidence-based recommendations to patient-based reality]. Beer S; Kunz GA; Ruiz J Rev Med Suisse; 2005 Jun; 1(22):1492-8. PubMed ID: 16025888 [TBL] [Abstract][Full Text] [Related]
3. Is family history a useful tool for detecting children at risk for diabetes and cardiovascular diseases? A public health perspective. Valdez R; Greenlund KJ; Khoury MJ; Yoon PW Pediatrics; 2007 Sep; 120 Suppl 2():S78-86. PubMed ID: 17767009 [TBL] [Abstract][Full Text] [Related]
4. [Time for a European perspective on cardiovascular prevention]. Nilsson PM; Perk J; Rydén L Lakartidningen; 2008 Apr 2-8; 105(14):1000-4. PubMed ID: 18478749 [No Abstract] [Full Text] [Related]
5. [Evidence-based reduction of complications of type 2 diabetes following intensive antihypertensive treatment]. Hansen KW; Poulsen PL; Mogensen CE Ugeskr Laeger; 1999 Aug; 161(34):4764. PubMed ID: 10500468 [No Abstract] [Full Text] [Related]
6. Screening for type 2 diabetes mellitus in adults. Fink K; Clark B Am Fam Physician; 2004 Feb; 69(3):605-6. PubMed ID: 14971844 [No Abstract] [Full Text] [Related]
7. For aggressive preventive management of type 2 diabetes. What is the evidence and is it enough? Genuth S J Fam Pract; 1998 Nov; 47(5 Suppl):S23-6. PubMed ID: 9834751 [No Abstract] [Full Text] [Related]
8. Diabetes as a 'cardiovascular disease equivalent': implications for treatment. Laakso M Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):682-3. PubMed ID: 18797431 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular prevention in patients with diabetes and prediabetes. Anselmino M; Gohlke H; Mellbin L; Rydén L Herz; 2008 Apr; 33(3):170-7. PubMed ID: 18568310 [TBL] [Abstract][Full Text] [Related]
11. Primary prevention of cardiovascular disease in people with dysglycemia. Bianchi C; Miccoli R; Penno G; Del Prato S Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487 [TBL] [Abstract][Full Text] [Related]
12. Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention. Mazzone T Am J Med; 2007 Sep; 120(9 Suppl 2):S26-32. PubMed ID: 17826043 [TBL] [Abstract][Full Text] [Related]
13. Implications of intensive glycemic control on cardiovascular disease: early reports from the ACCORD and ADVANCE Trials. Soo Yeon S; Nesto RW Rev Cardiovasc Med; 2008; 9(1):1-4. PubMed ID: 18418304 [No Abstract] [Full Text] [Related]
14. Type 2 diabetes mellitus: prevention of macrovascular complications. Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994 [TBL] [Abstract][Full Text] [Related]
15. [Non-insulin-dependent diabetes: an expanding disease. Importance of a multidisciplinary approach]. Lefebvre P Bull Acad Natl Med; 2003; 187(7):1307-15; discussion 1315-6. PubMed ID: 15146606 [TBL] [Abstract][Full Text] [Related]
16. The benefit of aspirin therapy in type 2 diabetes: what is the evidence? Sirois C; Poirier P; Moisan J; Grégoire JP Int J Cardiol; 2008 Sep; 129(2):172-9. PubMed ID: 18495263 [TBL] [Abstract][Full Text] [Related]
17. The prevention of cardiovascular disease: have we really made progress? Pearson TA Health Aff (Millwood); 2007; 26(1):49-60. PubMed ID: 17211013 [TBL] [Abstract][Full Text] [Related]